Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Adcytherix Launches with €30 Million in Seed Funding for Antibody Drug Conjugates
Details : The financing aims to fund Adcytherix to develop next-generation antibody-drug conjugates for the treatment of patients suffering from high unmet-need diseases such as neoplasms.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
November 06, 2024